We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Makers of in vitro diagnostics meant for research or investigational use only should take care not to encourage commercial use of their products. Read More
French medical devicemaker Carmat hopes to wrap up clinical studies of its artificial heart in Europe in time for a 2015 launch date — with eyes on U.S. market entry sometime thereafter. Read More
A federal court in California has ruled that using conventional diagnostic techniques in concert with a natural phenomenon does not add enough to make the end product patent-eligible. Read More
CardioInsight, an Ohio-based devicemaker specializing in mapping abnormal heart rhythms, has secured $15 million in long-term strategic financing for its noninvasive ECVUE monitoring system. Read More